{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:34:50Z","timestamp":1791153290965,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.vaccine.2010.05.019","type":"journal-article","created":{"date-parts":[[2010,5,21]],"date-time":"2010-05-21T08:46:57Z","timestamp":1274431617000},"page":"6393-6397","source":"Crossref","is-referenced-by-count":26,"title":["Studies on the usefulness of intranasal inactivated influenza vaccines"],"prefix":"10.1016","volume":"28","author":[{"given":"Shin-ichi","family":"Tamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.05.019_bib1","series-title":"Fields virology","first-page":"1353","article-title":"Orthomyxoviridae: the viruses and their replication","author":"Lamb","year":"1996"},{"key":"10.1016\/j.vaccine.2010.05.019_bib2","series-title":"Fields virology","first-page":"1397","article-title":"Orthomyxoviruses","author":"Murphy","year":"1996"},{"key":"10.1016\/j.vaccine.2010.05.019_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/JB.89.1.170-174.1965","article-title":"Induction of partial specific heterotypic immunity in mice by a single infection with influenza A virus","volume":"89","author":"Schulman","year":"1965","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2010.05.019_bib4","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/eji.1830100515","article-title":"Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice","volume":"10","author":"Webster","year":"1980","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2010.05.019_bib5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev.mi.37.100183.002525","article-title":"Immunity to influenza in man","volume":"37","author":"Couch","year":"1983","journal-title":"Ann Rev Microbiol"},{"key":"10.1016\/j.vaccine.2010.05.019_bib6","first-page":"107","article-title":"The systemic and mucosal immune response of humans to influenza A virus","volume":"146","author":"Murphy","year":"1989","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2010.05.019_bib7","series-title":"Handbook of mucosal immunology","first-page":"333","article-title":"Mucosal immunity to viruses","author":"Murphy","year":"1994"},{"key":"10.1016\/j.vaccine.2010.05.019_bib8","first-page":"75","article-title":"Cytotoxic T lymphocytes specific for influenza virus","volume":"189","author":"McMichael","year":"1994","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2010.05.019_bib9","first-page":"219","article-title":"Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral protein","volume":"53","author":"Chen","year":"2000","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.05.019_bib10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.7883\/yoken.JJID.2004.236","article-title":"Defense mechanisms against influenza virus infection in the respiratory tract mucosa","volume":"57","author":"Tamura","year":"2004","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.05.019_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7883\/yoken.JJID.2005.195","article-title":"Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccine","volume":"58","author":"Tamura","year":"2005","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.05.019_bib12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/213612a0","article-title":"Adaptation and growth characteristics of influenza virus at 25\u00b0C","volume":"213","author":"Maassab","year":"1967","journal-title":"Nature (London)"},{"key":"10.1016\/j.vaccine.2010.05.019_bib13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/oxfordjournals.aje.a121170","article-title":"Influenza antibody response following aerosol administration of inactivated virus","volume":"91","author":"Waldman","year":"1970","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2010.05.019_bib14","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1128\/IAI.40.3.1092-1095.1983","article-title":"Secretory immunological response after intranasal inactivated influenza A virus vaccination: evidence for immunoglobulin A memory","volume":"40","author":"Wright","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.05.019_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0264-410X(88)90140-5","article-title":"Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit","volume":"6","author":"Tamura","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.019_bib16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/eji.1830220228","article-title":"Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine","volume":"22","author":"Tamura","year":"1992","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2010.05.019_bib17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.4049\/jimmunol.149.3.981","article-title":"Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit","volume":"149","author":"Tamura","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.05.019_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0264-410X(94)90118-X","article-title":"Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine","volume":"12","author":"Tamura","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.019_bib19","series-title":"Mucosal vaccines","first-page":"425","article-title":"Intranasal immunization with influenza vaccine","author":"Tamura","year":"1996"},{"key":"10.1016\/j.vaccine.2010.05.019_bib20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000236862","article-title":"Knockout mice: how to make them and why. The immunological approach","volume":"106","author":"Fassler","year":"1995","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.vaccine.2010.05.019_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-1759(96)00243-8","article-title":"Isolation and characterization of mouse nasal-associated lymphoid tissue","volume":"202","author":"Asanuma","year":"1997","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2010.05.019_bib22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1099\/0022-1317-79-2-291","article-title":"Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection","volume":"79","author":"Tamura","year":"1998","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.05.019_bib23","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1099\/vir.0.79892-0","article-title":"Total viral genome copies and virus\u2013Ig complexes after infection with influenza virus in the nasal secretions of immunized mice","volume":"85","author":"Yoshikawa","year":"2004","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.05.019_bib24","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0264-410X(90)90250-P","article-title":"Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza","volume":"8","author":"Tamura","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.019_bib25","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/eji.1830210602","article-title":"Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different haemagglutinin molecules","volume":"21","author":"Tamura","year":"1991","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2010.05.019_bib26","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.4049\/jimmunol.168.6.2930","article-title":"Protection against influenza virus infection in poly Ig receptor-knockout mice immunized intranasally with adjuvant-combined vaccines","volume":"168","author":"Asahi","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.05.019_bib27","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1016\/S0264-410X(02)00351-1","article-title":"Immune responses against nasal adjuvant (CT112K)-combined influenza vaccine","volume":"20","author":"Watanabe","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.019_bib28","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/S0264-410X(03)00078-1","article-title":"Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia","volume":"21","author":"Ito","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.019_bib29","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.4049\/jimmunol.163.10.5367","article-title":"Generation of polymeric immunoglobulin receptor-deficient mouse with marked reduction of secretory IgA","volume":"163","author":"Shimada","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.05.019_bib30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/jmv.20173","article-title":"Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus","volume":"74","author":"Asahi-Ozaki","year":"2004","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2010.05.019_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0264-410X(95)00174-Y","article-title":"Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin in healthy volunteers","volume":"14","author":"Hashigucci","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.019_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.11150\/kansenshogakuzasshi1970.71.153","article-title":"Efficacy of nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin in healthy volunteers","volume":"71","author":"Hashigucci","year":"1997","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.vaccine.2010.05.019_bib33","first-page":"8","article-title":"Intranasal immunization for human application","volume":"5","author":"Tamura","year":"1997","journal-title":"Mucosal Immunol Update"},{"key":"10.1016\/j.vaccine.2010.05.019_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7883\/yoken.63.8","article-title":"Estimation of the effective doses of nasal-inactivated influenza vaccine in humans from mouse-model experiments","volume":"63","author":"Tamura","year":"2010","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.05.019_bib35","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1016\/S0264-410X(03)00234-2","article-title":"Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza a virus infection in mice","volume":"21","author":"Takada","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.019_bib36","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1073\/pnas.0400937101","article-title":"Recognition of single-stranded RNA viruses by Toll-like receptor 7","volume":"101","author":"Lund","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2010.05.019_bib37","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1093616","article-title":"Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA","volume":"303","author":"Diebold","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2010.05.019_bib38","doi-asserted-by":"crossref","first-page":"9624","DOI":"10.1128\/JVI.78.18.9624-9632.2004","article-title":"Intranasal immunization with inactivated influenza virus enhances immune responses to coadministered simian-human immunodeficiency virus-like particle antigens","volume":"78","author":"Kang","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.05.019_bib39","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/S0264-410X(00)00055-4","article-title":"Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin)","volume":"18","author":"Matsuo","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.019_bib40","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/jmv.20837","article-title":"Prophylactic effects of chitin microparticles on highly pathogenic H5N1 influenza virus","volume":"79","author":"Ichinohe","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2010.05.019_bib41","series-title":"Textbook of influenza","first-page":"373","article-title":"Live cold-adapted, reassortant influenza vaccines (USA)","author":"Keitel","year":"1998"},{"issue":"PR08","key":"10.1016\/j.vaccine.2010.05.019_bib42","first-page":"1","article-title":"Recommendations of the ACIP: prevention and control of seasonal influenza with vaccines","volume":"58","author":"CDC","year":"2009","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2010.05.019_bib43","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1016\/S0264-410X(03)00457-2","article-title":"Mucosal antibody responses induced with a nasal virosome-based influenza vaccine","volume":"21","author":"Durrer","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.019_bib44","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccines and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2010.05.019_bib45","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/90609","article-title":"Toll-like receptors: critical proteins linking innate and acquired immunity","volume":"2","author":"Akira","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2010.05.019_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-4889(01)00182-3","article-title":"Toll-like receptors as adjuvant receptors","volume":"1589","author":"Kaisho","year":"2002","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.vaccine.2010.05.019_bib47","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1586\/14760584.7.9.1435","article-title":"Innate sensors of influenza virus: clues to developing better intranasal vaccines","volume":"7","author":"Ichinohe","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2010.05.019_bib48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1084\/jem.20081667","article-title":"Inflammasome recognition of influenza virus is essential for adaptive immune responses","volume":"206","author":"Ichinohe","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.05.019_bib49","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0264-410X(98)80122-9","article-title":"CpG DNA, a novel immune enhancer for systemic and mucosa immunization with influenza virus","volume":"16","author":"Moldoveanu","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.019_bib50","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/35047202","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2010.05.019_bib51","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1128\/JVI.79.5.2847-2858.2005","article-title":"Involvement of Toll-like receptor 9 signaling pathway in the induction of innate immunity by Baculovirus","volume":"79","author":"Abe","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.05.019_bib52","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappa B by Toll-like receptor 3","volume":"423","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2010.05.019_bib53","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1128\/JVI.79.5.2910-2919.2005","article-title":"Synthetic double-stranded RNA [poly(I:C)]combined with mucosal vaccine protects against influenza virus infection","volume":"79","author":"Ichinohe","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.05.019_bib54","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/521304","article-title":"Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated vaccine","volume":"196","author":"Ichinohe","year":"2007","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1000695X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1000695X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T01:29:23Z","timestamp":1740101363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1000695X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":54,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0264410X1000695X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.05.019","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}